Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation
- Type
- Retraction
- Notice date
- 5/30/2023 0:00
- Journal
- Pharmaceutics
- Publisher
- MDPI
- Notice DOI
- 10.3390/pharmaceutics15061623
- Original paper DOI
- 10.3390/pharmaceutics13030330
Reasons
- Duplication of/in Image
- Investigation by Journal/Publisher
- Original Data and/or Images not Provided and/or not Available
- Unreliable Results and/or Conclusions